FLT3 and acute lymphoblastic leukemia: In fact, gilteritinib LC50 was negatively correlated with FLT3 mRNA expression (r = −0.9, P = 0.0002) and protein expression on the cell surface (r = −0.8364, P = 0.0013) across 11 ALL cell lines (Supplementary Fig. 3).